Skip to content

Dxcover vs Mercy BioAnalytics, Inc.

Dxcover logo

Dxcover

The Future of Cancer Diagnostics

24 employees · est. 2016

VS
Mercy BioAnalytics, Inc. logo

Mercy BioAnalytics, Inc.

We are making early stage cancer easier to find

62 employees · est. 2018 · Waltham, United States

Dxcover is the older company (2016 vs 2018); Mercy BioAnalytics, Inc. is the larger of the two.

Side-by-Side Comparison

Dxcover Mercy BioAnalytics, Inc.
Founded
2016 older 2018
Headquarters
Not tracked yet Waltham, United States
Employees
24 62 larger
Industry
Biotechnology, Health Care, Machine Learning Biotechnology, Health Care, Health and Wellness
Funding Stage
Series A Series B
Total Funding
$14.40M $127.28M
Funding Rounds
6 3
Taxonomy
Liquid BiopsyCancer DiagnosticsEarly DetectionInfrared SpectroscopyClinical StageBiomarkers +5 Cancer DetectionLiquid BiopsyExtracellular VesiclesEarly Stage Cancer DetectionHealthcare Innovation
Website
dxcover.com mercybio.com
Dxcover logo

About Dxcover

Dxcover is a clinical stage liquid biopsy company that focuses on the early detection of multiple cancers for more effective treatment outcomes. Using infrared spectroscopy of circulating pan-omic biomarkers, the company has pioneered the early detection and identification of cancer, with compelling...

Mercy BioAnalytics, Inc. logo

About Mercy BioAnalytics, Inc.

Mercy BioAnalytics, Inc. is a groundbreaking biotechnology startup based in the United States that is dedicated to revolutionizing cancer detection. The company's slogan, "We are making early stage cancer easier to find," succinctly captures their mission. Founded in 2018, Mercy BioAnalytics has gar...

Also comparing in this category

Comparing more than these two?

Get Dxcover, Mercy BioAnalytics, Inc. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Dxcover compare?

A PDF of Dxcover and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Dxcover was founded in 2016, with 24 employees. Dxcover is a clinical stage liquid biopsy company that focuses on the early detection of multiple cancers for more effective treatment outcomes. Using infrared spectroscopy of circulating pan-omic bio. Mercy BioAnalytics, Inc. was founded in 2018, based in Waltham, United States, with 62 employees. Mercy BioAnalytics, Inc. is a groundbreaking biotechnology startup based in the United States that is dedicated to revolutionizing cancer detection. The company's slogan, "We are making early stage ca.
Dxcover has raised $14.40M and Mercy BioAnalytics, Inc. $127.28M. Latest stage: Dxcover Series A, Mercy BioAnalytics, Inc. Series B.
Both work in Biotechnology and Health Care and list liquid biopsy among their focus areas.

Compare Dxcover with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Dxcover on 12 Sep 2024, and Mercy BioAnalytics, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout